Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200295170> ?p ?o ?g. }
- W4200295170 endingPage "448" @default.
- W4200295170 startingPage "437" @default.
- W4200295170 abstract "Canine mammary tumours (CMTs) are the most common neoplasms in intact bitches, and few chemotherapeutic options are available for highly invasive and metastatic tumours. Recent studies have shown the potential involvement of dysregulated Hippo signalling in CMT development and progression. Statins can activate the Hippo pathway by blocking protein geranylgeranylation (GGylation), resulting in decreased expression and activity of the transcriptional co-activators YAP and TAZ. In this study, we therefore sought to determine if statins could exert anti-cancer effects in CMT cells. Our results demonstrate that Atorvastatin and Fluvastatin are cytotoxic to two CMT cell lines (CMT9 and CMT47), with ED50 values ranging from 0.95 to 23.5 μM. Both statins acted to increase apoptosis and promote cell cycle arrest. Both statins also decreased YAP and TAZ expression and reduced the mRNA levels of key Hippo transcriptional target genes known to be involved in breast cancer progression and chemoresistance (CYR61, CTGF and RHAMM). Moreover, both statins effectively inhibited cell migration and anchorage independent growth, but did not influence matrix invasion. Taken together, our results demonstrate for the first time that statins act upon the Hippo pathway in CMT cells to counteract several molecular and cellular hallmarks of cancer. These findings suggest that targeting the Hippo pathway with statins represents a novel and promising approach for the treatment canine mammary gland cancers." @default.
- W4200295170 created "2021-12-31" @default.
- W4200295170 creator A5000121479 @default.
- W4200295170 creator A5021621503 @default.
- W4200295170 creator A5053329553 @default.
- W4200295170 creator A5059918709 @default.
- W4200295170 date "2021-12-19" @default.
- W4200295170 modified "2023-10-15" @default.
- W4200295170 title "Statins downregulate <scp>YAP</scp> and <scp>TAZ</scp> and exert anti‐cancer effects in canine mammary tumour cells" @default.
- W4200295170 cites W1656750119 @default.
- W4200295170 cites W1754956540 @default.
- W4200295170 cites W1826944293 @default.
- W4200295170 cites W1878812720 @default.
- W4200295170 cites W1896237858 @default.
- W4200295170 cites W1909809324 @default.
- W4200295170 cites W1919128420 @default.
- W4200295170 cites W1967560169 @default.
- W4200295170 cites W1972242272 @default.
- W4200295170 cites W1977291335 @default.
- W4200295170 cites W1977970155 @default.
- W4200295170 cites W1983357849 @default.
- W4200295170 cites W1990114889 @default.
- W4200295170 cites W1995077721 @default.
- W4200295170 cites W1995997868 @default.
- W4200295170 cites W2000523214 @default.
- W4200295170 cites W2004191401 @default.
- W4200295170 cites W2004480757 @default.
- W4200295170 cites W2027587678 @default.
- W4200295170 cites W2035491352 @default.
- W4200295170 cites W2039944972 @default.
- W4200295170 cites W2040430549 @default.
- W4200295170 cites W2044166463 @default.
- W4200295170 cites W2049976919 @default.
- W4200295170 cites W2053738982 @default.
- W4200295170 cites W2057626690 @default.
- W4200295170 cites W2060978652 @default.
- W4200295170 cites W2065461844 @default.
- W4200295170 cites W2085197940 @default.
- W4200295170 cites W2090892239 @default.
- W4200295170 cites W2093257326 @default.
- W4200295170 cites W2105782572 @default.
- W4200295170 cites W2107277218 @default.
- W4200295170 cites W2109322526 @default.
- W4200295170 cites W2109838283 @default.
- W4200295170 cites W2114643610 @default.
- W4200295170 cites W2116426583 @default.
- W4200295170 cites W2129732555 @default.
- W4200295170 cites W2141595533 @default.
- W4200295170 cites W2149372808 @default.
- W4200295170 cites W2158805914 @default.
- W4200295170 cites W2159038842 @default.
- W4200295170 cites W2167978765 @default.
- W4200295170 cites W2176613862 @default.
- W4200295170 cites W2292279194 @default.
- W4200295170 cites W2418415843 @default.
- W4200295170 cites W2522190852 @default.
- W4200295170 cites W2534069516 @default.
- W4200295170 cites W2555188435 @default.
- W4200295170 cites W2557569375 @default.
- W4200295170 cites W2590266658 @default.
- W4200295170 cites W2724348609 @default.
- W4200295170 cites W2758030386 @default.
- W4200295170 cites W2768903923 @default.
- W4200295170 cites W2774700311 @default.
- W4200295170 cites W2791031844 @default.
- W4200295170 cites W2794799252 @default.
- W4200295170 cites W2803503605 @default.
- W4200295170 cites W2887600684 @default.
- W4200295170 cites W2895263771 @default.
- W4200295170 cites W2899655237 @default.
- W4200295170 cites W2917222676 @default.
- W4200295170 cites W2917985234 @default.
- W4200295170 cites W2942454265 @default.
- W4200295170 cites W2979557899 @default.
- W4200295170 cites W3003732033 @default.
- W4200295170 cites W3035734167 @default.
- W4200295170 cites W3064232111 @default.
- W4200295170 cites W3204905415 @default.
- W4200295170 cites W41026058 @default.
- W4200295170 doi "https://doi.org/10.1111/vco.12789" @default.
- W4200295170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34881506" @default.
- W4200295170 hasPublicationYear "2021" @default.
- W4200295170 type Work @default.
- W4200295170 citedByCount "7" @default.
- W4200295170 countsByYear W42002951702021 @default.
- W4200295170 countsByYear W42002951702022 @default.
- W4200295170 countsByYear W42002951702023 @default.
- W4200295170 crossrefType "journal-article" @default.
- W4200295170 hasAuthorship W4200295170A5000121479 @default.
- W4200295170 hasAuthorship W4200295170A5021621503 @default.
- W4200295170 hasAuthorship W4200295170A5053329553 @default.
- W4200295170 hasAuthorship W4200295170A5059918709 @default.
- W4200295170 hasConcept C104317684 @default.
- W4200295170 hasConcept C121608353 @default.
- W4200295170 hasConcept C126322002 @default.
- W4200295170 hasConcept C127561419 @default.
- W4200295170 hasConcept C170493617 @default.
- W4200295170 hasConcept C172512520 @default.